Opportunity Information: Apply for M OAA GH 09 252
Apply for M OAA GH 09 252
- The Agency for International Development in the health sector is offering a public funding opportunity titled "Malaria Communities Program FY09 RFA" and is now available to receive applicants.
- This funding opportunity was created on Feb 5, 2009 and posted on Dec 4, 2008.
- Applicants must submit their applications by Feb 11, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- U.S. based and international non governmental organizations/private voluntary organizations and in country (see below Section III.B, Eligible Countries) non governmental organizations are eligible to submit applications. Further, to be eligible for grant funding under this RFA, a legally constituted organization must not have been awarded in excess of 5 million in total, direct U.S Government funding over the five years prior to submission of an application under this RFA. Under this RFA, direct U.S. Government funding does not include 1) U.S. Government emergency and disaster assistance, whether domestic or international, or 2) U.S. Government domestic or international funding received by virtue of a subcontract or sub grant. The 5 million eligibility limitation applies not only to the principal applicant but to any organization with which the principal applicant may choose to enter into a subcontract or grant. Please refer to the Eligibility section in the RFA for more detailed eligibility information.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Malaria Communities Program (MCP) FY09 Request for Applications (RFA) is a USAID funding opportunity under the President's Malaria Initiative (PMI) designed to bring in new partner organizations to implement sustainable malaria prevention and control activities in PMI focus countries. The central goal is to support organizations that have not traditionally received large amounts of direct U.S. government funding, so they can contribute meaningfully to country-led malaria efforts while building local capacity and long-term sustainability. MCP was originally announced on December 14, 2006, and this FY09 round continues that model of intentionally widening the circle of implementing partners beyond the usual large contractors and grantees.
Projects funded through this opportunity are expected to operate within existing PMI and host-country malaria strategies rather than running parallel programs. Awardees are expected to work under the leadership of the in-country USAID Mission, with support from the PMI team (which includes staff from USAID and the Centers for Disease Control and Prevention), and in coordination with National Malaria Control Programs (NMCPs) and other malaria partners already active in PMI focus countries. A major emphasis is placed on strengthening local and indigenous capacity, meaning applicants should be thinking not only about delivering services or commodities, but also about how their approach will leave behind stronger systems, more capable local organizations, and more durable host-nation ownership once the award ends.
The award instrument is a cooperative agreement, which typically means the government anticipates substantial involvement during implementation, such as technical collaboration, oversight, and ongoing coordination with USAID and PMI leadership. The activity area is health, specifically malaria prevention and control. While the announcement does not list a required cost share or match, it clearly frames the program around sustainability and coordination, so successful applications would generally be expected to show practical plans for integration with national systems and partners, as well as feasible approaches for continuation beyond the life of the award.
Funding under this RFA has an award ceiling of $1,500,000, with no stated minimum award amount. The opportunity is identified by Funding Opportunity Number M-OAA-GH-09-252 and is categorized as continuation. Key dates included a posted date of December 4, 2008, and a closing date that was extended to February 11, 2009 (from an original closing date of February 6, 2009). The opportunity was later archived on March 8, 2009.
Eligibility is focused on U.S.-based and international nongovernmental organizations/private voluntary organizations, as well as in-country nongovernmental organizations located in eligible countries (the specific list is referenced in the RFA under Section III.B). The defining eligibility restriction is a funding cap meant to ensure the program truly reaches new or smaller partners: to qualify, a legally constituted organization must not have been awarded more than $5 million in total direct U.S. government funding over the five years prior to applying. Two types of funding are explicitly excluded from that calculation: (1) U.S. government emergency and disaster assistance, domestic or international, and (2) funding received as a subcontractor or subgrantee (since that is not counted as direct funding to the organization). Importantly, the $5 million limitation applies not only to the prime applicant but also to any organization the applicant plans to fund through a subcontract or subgrant arrangement, which pushes applicants to build teams that still meet the "new partner" intent of the program.
Overall, this RFA is best understood as a PMI mechanism that prioritizes expanding the base of implementing partners while maintaining alignment with national malaria control strategies. Applicants are expected to deliver tangible malaria prevention and control results in PMI focus countries while also strengthening local institutions and partnerships, coordinating closely with USAID Missions, PMI technical leadership, NMCPs, and existing malaria stakeholders. For applicants needing help accessing the full announcement, the listed government point of contact is Jamie Alissa Beck, Contract Specialist, at 202-712-1427.
Frequently Asked Questions (FAQs) - Malaria Communities Program (MCP) FY09 RFA
What is the Malaria Communities Program (MCP) FY09 Request for Applications (RFA)?
The MCP FY09 RFA is a USAID funding opportunity under the President's Malaria Initiative (PMI). It is designed to bring in new partner organizations to implement sustainable malaria prevention and control activities in PMI focus countries.
What is the main purpose of this funding opportunity?
The central goal is to expand the circle of implementing partners beyond the usual large contractors and grantees by supporting organizations that have not traditionally received large amounts of direct U.S. government funding. The program aims to help these organizations contribute to country-led malaria efforts while building local capacity and long-term sustainability.
How does this FY09 round relate to earlier MCP announcements?
MCP was originally announced on December 14, 2006. The FY09 round continues the same model of intentionally widening participation to new or smaller partners.
What type of award is used for this opportunity?
The award instrument is a cooperative agreement.
What does it mean that the award is a "cooperative agreement"?
A cooperative agreement typically means the U.S. government anticipates substantial involvement during implementation. In this opportunity, that involvement may include technical collaboration, oversight, and ongoing coordination with USAID and PMI leadership.
What is the program area or sector for this RFA?
The activity area is health, specifically malaria prevention and control.
Where are projects expected to be implemented?
Projects are expected to operate in PMI focus countries and align with host-country malaria strategies.
Do projects need to align with existing PMI and national malaria strategies?
Yes. Funded projects are expected to operate within existing PMI and host-country malaria strategies rather than running parallel programs.
Who provides leadership and coordination in-country for awardees?
Awardees are expected to work under the leadership of the in-country USAID Mission, with support from the PMI team (including USAID and the Centers for Disease Control and Prevention), and in coordination with National Malaria Control Programs (NMCPs) and other malaria partners active in PMI focus countries.
What is emphasized regarding local capacity and sustainability?
A major emphasis is placed on strengthening local and indigenous capacity. Applicants are expected to think beyond delivering services or commodities and include how their approach will leave behind stronger systems, more capable local organizations, and more durable host-nation ownership after the award ends.
What is the maximum funding amount available per award?
The award ceiling is $1,500,000.
Is there a minimum award amount stated?
No minimum award amount is stated in the information provided.
Is cost share or matching required?
The announcement does not list a required cost share or match. However, the program is framed around sustainability and coordination, so applications would generally be expected to describe practical plans for integration and continuation beyond the award period.
What is the Funding Opportunity Number for this RFA?
The Funding Opportunity Number is M-OAA-GH-09-252.
How is this opportunity categorized?
The opportunity is categorized as continuation.
When was the opportunity posted and when did it close?
The posted date was December 4, 2008. The closing date was extended to February 11, 2009, from an original closing date of February 6, 2009.
Is this funding opportunity still open?
No. The opportunity was archived on March 8, 2009.
Who is eligible to apply?
Eligibility is focused on U.S.-based and international nongovernmental organizations/private voluntary organizations, as well as in-country nongovernmental organizations located in eligible countries (referenced in the RFA under Section III.B).
What is the key eligibility restriction related to prior U.S. government funding?
To qualify, a legally constituted organization must not have been awarded more than $5 million in total direct U.S. government funding over the five years prior to applying.
What types of funding do not count toward the $5 million direct U.S. government funding limit?
Two types of funding are explicitly excluded from the calculation: (1) U.S. government emergency and disaster assistance (domestic or international), and (2) funding received as a subcontractor or subgrantee, since that is not considered direct funding to the organization.
Does the $5 million funding limit apply only to the prime applicant?
No. The $5 million limitation applies both to the prime applicant and to any organization the applicant plans to fund through a subcontract or subgrant arrangement.
What does the eligibility cap mean for teaming and partnerships?
Because the $5 million cap applies to the prime applicant and any organizations to be funded via subcontracts or subgrants, applicants are expected to build teams that still meet the "new partner" intent of the program.
What kinds of results are applicants expected to achieve?
Applicants are expected to deliver tangible malaria prevention and control results in PMI focus countries while also strengthening local institutions and partnerships and coordinating closely with USAID Missions, PMI technical leadership, NMCPs, and existing malaria stakeholders.
Who can be contacted for help accessing the full announcement?
The listed government point of contact is Jamie Alissa Beck, Contract Specialist, at 202-712-1427.
Browse more opportunities from the same category: Health
Next opportunity: Influenza and Other Emerging Infectious Diseases in Vietnam (U01)
Previous opportunity: Ralph Steckler/Space Grant Space Colonization Research and Technology Development Opportunity Phase I
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for M OAA GH 09 252
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (M OAA GH 09 252) also looked into and applied for these:
| Funding Opportunity |
|---|
| Influenza and Other Emerging Infectious Diseases in Vietnam (U01) Apply for RFA IP 09 002 Funding Number: RFA IP 09 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Research and Public Health Practice on Influenza and other respiratory infectious diseases in the Middle East, Southeast Asia, and South American regions Apply for RFA IP 09 004 Funding Number: RFA IP 09 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
| Academic Research Enhancement Award (R15) Apply for PA 06 042 Funding Number: PA 06 042 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Patient Oriented Research Grant (R21) Apply for PA 06 086 Funding Number: PA 06 086 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIDCR Small Research Grants for Data Analysis and Statistical Methodology (R03) Apply for PAR 06 211 Funding Number: PAR 06 211 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Retirement Economics (R03) Apply for PA 06 235 Funding Number: PA 06 235 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Retirement Economics (R21) Apply for PA 06 236 Funding Number: PA 06 236 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Ancillary Studies to the AD Neuroimaging Initiative (R03) Apply for PA 06 240 Funding Number: PA 06 240 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Ancillary Studies to the Ad Neuroimaging Initiative (R21) Apply for PA 06 241 Funding Number: PA 06 241 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Aging Musculoskeletal and Skin Extracellular Matrix (R21) Apply for PA 06 242 Funding Number: PA 06 242 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| From Intervention Development to Services Exploratory Research Grants (R34) Apply for PAR 06 248 Funding Number: PAR 06 248 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Rapid Assessment Post Impact of Disaster (R03) Apply for PAR 06 252 Funding Number: PAR 06 252 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Rapid Assessment Post Impact of Disaster (R21) Apply for PAR 06 253 Funding Number: PAR 06 253 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Grants for Alzheimers Disease Drug Discovery (R21) Apply for PAS 06 261 Funding Number: PAS 06 261 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Temporomandibular Joint and Muscle Disorders Pathophysiological Mechanisms Linking Comorbid Conditions (R03) Apply for PA 06 267 Funding Number: PA 06 267 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Temporomandibular Joint and Muscle Disorders Pathophysiological Mechanisms Linking Comorbid Conditions (R21) Apply for PA 06 268 Funding Number: PA 06 268 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NEI Research Grant for Secondary Data Analysis (R21) Apply for PAR 06 326 Funding Number: PAR 06 326 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Womens Mental Health and Sex/Gender Differences Research (R21) Apply for PA 06 334 Funding Number: PA 06 334 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Planning Grants For Translational Research For The Prevention And Control Of Diabetes And Obesity (R34) Apply for PAR 06 358 Funding Number: PAR 06 358 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Cell Lineage and Developmental Studies in Hearing and Balance (R21) Apply for PA 06 365 Funding Number: PA 06 365 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "M OAA GH 09 252", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.